NM_001099780.2:c.145G>A

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 1P and 20B. PP3BP4_StrongBP6_Very_StrongBS1BS2

The NM_001099780.2(PSMB11):​c.145G>A​(p.Gly49Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00698 in 1,613,660 control chromosomes in the GnomAD database, including 59 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0060 ( 7 hom., cov: 33)
Exomes 𝑓: 0.0071 ( 52 hom. )

Consequence

PSMB11
NM_001099780.2 missense

Scores

11
4
3

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 8.96

Publications

14 publications found
Variant links:
Genes affected
PSMB11 (HGNC:31963): (proteasome subunit beta 11) Proteasomes generate peptides that are presented by major histocompatibility complex (MHC) I molecules to other cells of the immune system. Proteolysis is conducted by 20S proteasomes, complexes of 28 subunits arranged as a cylinder in 4 heteroheptameric rings: alpha-1 to -7, beta-1 to -7, beta-1 to -7, and alpha-1 to -7. The catalytic subunits are beta-1 (PSMB6; MIM 600307), beta-2 (PSMB7; MIM 604030), and beta-5 (PSMB5; MIM 600306). Three additional subunits, beta-1i (PSMB9; MIM 177045), beta-2i (PSMB10; MIM 176847), and beta-5i (PSMB8; MIM 177046), are induced by gamma-interferon (IFNG; MIM 147570) and are preferentially incorporated into proteasomes to make immunoproteasomes. PSMB11, or beta-5t, is a catalytic subunit expressed exclusively in cortical thymic epithelial cells (Murata et al., 2007 [PubMed 17540904]).[supplied by OMIM, Mar 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

PP3
Multiple lines of computational evidence support a deleterious effect 9: AlphaMissense, BayesDel_noAF, Cadd, Eigen, MutationAssessor, phyloP100way_vertebrate, PROVEAN, REVEL, REVEL [when max_spliceai, FATHMM_MKL, MetaRNN, MutationTaster was below the threshold]
BP4
Computational evidence support a benign effect (MetaRNN=0.015518874).
BP6
Variant 14-23042370-G-A is Benign according to our data. Variant chr14-23042370-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 771191.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.00598 (911/152266) while in subpopulation EAS AF = 0.0274 (142/5174). AF 95% confidence interval is 0.0238. There are 7 homozygotes in GnomAd4. There are 435 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 7 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PSMB11NM_001099780.2 linkc.145G>A p.Gly49Ser missense_variant Exon 1 of 1 ENST00000408907.5 NP_001093250.1 A5LHX3B3KVC3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PSMB11ENST00000408907.5 linkc.145G>A p.Gly49Ser missense_variant Exon 1 of 1 6 NM_001099780.2 ENSP00000386212.2 A5LHX3

Frequencies

GnomAD3 genomes
AF:
0.00595
AC:
906
AN:
152150
Hom.:
7
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00142
Gnomad AMI
AF:
0.00219
Gnomad AMR
AF:
0.00445
Gnomad ASJ
AF:
0.00432
Gnomad EAS
AF:
0.0274
Gnomad SAS
AF:
0.00207
Gnomad FIN
AF:
0.0114
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.00691
Gnomad OTH
AF:
0.00718
GnomAD2 exomes
AF:
0.00742
AC:
1848
AN:
248998
AF XY:
0.00743
show subpopulations
Gnomad AFR exome
AF:
0.00123
Gnomad AMR exome
AF:
0.00353
Gnomad ASJ exome
AF:
0.00348
Gnomad EAS exome
AF:
0.0220
Gnomad FIN exome
AF:
0.0132
Gnomad NFE exome
AF:
0.00770
Gnomad OTH exome
AF:
0.00810
GnomAD4 exome
AF:
0.00709
AC:
10359
AN:
1461394
Hom.:
52
Cov.:
32
AF XY:
0.00710
AC XY:
5162
AN XY:
727030
show subpopulations
African (AFR)
AF:
0.00111
AC:
37
AN:
33480
American (AMR)
AF:
0.00335
AC:
150
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00371
AC:
97
AN:
26130
East Asian (EAS)
AF:
0.0256
AC:
1018
AN:
39700
South Asian (SAS)
AF:
0.00220
AC:
190
AN:
86256
European-Finnish (FIN)
AF:
0.0135
AC:
714
AN:
52962
Middle Eastern (MID)
AF:
0.00624
AC:
36
AN:
5766
European-Non Finnish (NFE)
AF:
0.00692
AC:
7697
AN:
1111992
Other (OTH)
AF:
0.00696
AC:
420
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
657
1315
1972
2630
3287
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
298
596
894
1192
1490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00598
AC:
911
AN:
152266
Hom.:
7
Cov.:
33
AF XY:
0.00584
AC XY:
435
AN XY:
74450
show subpopulations
African (AFR)
AF:
0.00142
AC:
59
AN:
41562
American (AMR)
AF:
0.00451
AC:
69
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00432
AC:
15
AN:
3472
East Asian (EAS)
AF:
0.0274
AC:
142
AN:
5174
South Asian (SAS)
AF:
0.00207
AC:
10
AN:
4826
European-Finnish (FIN)
AF:
0.0114
AC:
121
AN:
10610
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.00691
AC:
470
AN:
68004
Other (OTH)
AF:
0.00900
AC:
19
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
43
86
128
171
214
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00687
Hom.:
14
Bravo
AF:
0.00549
TwinsUK
AF:
0.00539
AC:
20
ALSPAC
AF:
0.00519
AC:
20
ESP6500AA
AF:
0.000690
AC:
3
ESP6500EA
AF:
0.00622
AC:
53
ExAC
AF:
0.00746
AC:
904
EpiCase
AF:
0.00725
EpiControl
AF:
0.00931

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.57
BayesDel_addAF
Uncertain
0.063
T
BayesDel_noAF
Pathogenic
0.33
CADD
Pathogenic
26
DANN
Uncertain
1.0
DEOGEN2
Benign
0.34
T
Eigen
Pathogenic
0.95
Eigen_PC
Pathogenic
0.84
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Pathogenic
1.0
D
MetaRNN
Benign
0.016
T
MetaSVM
Uncertain
0.36
D
MutationAssessor
Pathogenic
4.0
H
PhyloP100
9.0
PrimateAI
Uncertain
0.70
T
PROVEAN
Pathogenic
-5.5
D
REVEL
Pathogenic
0.73
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Polyphen
1.0
D
Vest4
0.92
MVP
0.87
MPC
0.61
ClinPred
0.099
T
GERP RS
5.4
PromoterAI
0.0021
Neutral
Varity_R
0.90
gMVP
0.88
Mutation Taster
=85/15
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34457782; hg19: chr14-23511579; COSMIC: COSV109440365; COSMIC: COSV109440365; API